These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 18656241)

  • 1. Stem cell marker expression in small cell lung carcinoma and developing lung tissue.
    Koch LK; Zhou H; Ellinger J; Biermann K; Höller T; von Rücker A; Büttner R; Gütgemann I
    Hum Pathol; 2008 Nov; 39(11):1597-605. PubMed ID: 18656241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
    Rudin CM; Durinck S; Stawiski EW; Poirier JT; Modrusan Z; Shames DS; Bergbower EA; Guan Y; Shin J; Guillory J; Rivers CS; Foo CK; Bhatt D; Stinson J; Gnad F; Haverty PM; Gentleman R; Chaudhuri S; Janakiraman V; Jaiswal BS; Parikh C; Yuan W; Zhang Z; Koeppen H; Wu TD; Stern HM; Yauch RL; Huffman KE; Paskulin DD; Illei PB; Varella-Garcia M; Gazdar AF; de Sauvage FJ; Bourgon R; Minna JD; Brock MV; Seshagiri S
    Nat Genet; 2012 Oct; 44(10):1111-6. PubMed ID: 22941189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway.
    Ding Y; Wang X; Shu F; Pan K; Chen X; Liu Q
    J Mol Histol; 2024 Aug; ():. PubMed ID: 39198365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocalyxin in Normal Tissue and Epithelial Cancer.
    Le Tran N; Wang Y; Nie G
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.
    Maroni G; Bassal MA; Krishnan I; Fhu CW; Savova V; Zilionis R; Maymi VA; Pandell N; Csizmadia E; Zhang J; Storti B; Castaño J; Panella R; Li J; Gustafson CE; Fox S; Levy RD; Meyerovitz CV; Tramontozzi PJ; Vermilya K; De Rienzo A; Crucitta S; Bassères DS; Weetall M; Branstrom A; Giorgetti A; Ciampi R; Del Re M; Danesi R; Bizzarri R; Yang H; Kocher O; Klein AM; Welner RS; Bueno R; Magli MC; Clohessy JG; Ali A; Tenen DG; Levantini E
    Commun Biol; 2021 Apr; 4(1):370. PubMed ID: 33854168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway.
    Lin YY; Wang CY; Phan NN; Chiao CC; Li CY; Sun Z; Hung JH; Chen YL; Yen MC; Weng TY; Hsu HP; Lai MD
    Int J Med Sci; 2020; 17(11):1639-1651. PubMed ID: 32669966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma.
    Tamayo-Orbegozo E; Amo L; Díez-García J; Amutio E; Riñón M; Alonso M; Arana P; Maruri N; Larrucea S
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
    Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G
    Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2.
    Itai S; Yamada S; Kaneko MK; Sano M; Nakamura T; Yanaka M; Handa S; Hisamatsu K; Nakamura Y; Furusawa Y; Fukui M; Ohishi T; Kawada M; Harada H; Kato Y
    Biochem Biophys Rep; 2018 Sep; 15():93-96. PubMed ID: 30105309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of critical epitope of PcMab-47 against human podocalyxin.
    Itai S; Yamada S; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2018 Jul; 14():78-82. PubMed ID: 29872738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell surface markers on normal stem cells.
    Kim WT; Ryu CJ
    BMB Rep; 2017 Jun; 50(6):285-298. PubMed ID: 28270302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
    Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
    Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.
    Yong KJ; Basseres DS; Welner RS; Zhang WC; Yang H; Yan B; Alberich-Jorda M; Zhang J; de Figueiredo-Pontes LL; Battelli C; Hetherington CJ; Ye M; Zhang H; Maroni G; O'Brien K; Magli MC; Borczuk AC; Varticovski L; Kocher O; Zhang P; Moon YC; Sydorenko N; Cao L; Davis TW; Thakkar BM; Soo RA; Iwama A; Lim B; Halmos B; Neuberg D; Tenen DG; Levantini E
    Sci Transl Med; 2016 Aug; 8(350):350ra104. PubMed ID: 27488898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
    Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
    Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer stem cells-characteristics, phenotype.
    Hardavella G; George R; Sethi T
    Transl Lung Cancer Res; 2016 Jun; 5(3):272-9. PubMed ID: 27413709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in small cell lung cancer.
    Codony-Servat J; Verlicchi A; Rosell R
    Transl Lung Cancer Res; 2016 Feb; 5(1):16-25. PubMed ID: 26958490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.
    Amo L; Tamayo-Orbegozo E; Maruri N; Eguizabal C; Zenarruzabeitia O; Riñón M; Arrieta A; Santos S; Monge J; Vesga MA; Borrego F; Larrucea S
    Front Oncol; 2014; 4():245. PubMed ID: 25309871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of lung cancer.
    Langevin SM; Kratzke RA; Kelsey KT
    Transl Res; 2015 Jan; 165(1):74-90. PubMed ID: 24686037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.